YCBD (cbdmd.com) Rega marang bathi mangsa ngarep
The forward P/E ratio for cbdMD, Inc. (YCBD) correlates with the implementation of ESG environmental standards and the transition to biodegradable packaging. The 0.00 mark reflects the asset's current state amid severe pricing pressure within the CBD product niche. Meanwhile, the business relies on full outsourcing of production and logistics, focusing exclusively on marketing and brand visual identity.
Ringkesan rincian data analitis cbdMD Corp (YCBD)
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- data tingkat utang lan likuiditas finansial:
Total Utang marang Modal cbdMD, Inc.|YCBD - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas cbdMD, Inc.|YCBD - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku cbdMD Inc.|YCBD - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan cbdMD|Rasio cepet cbdmd.com
- rincian asil keuangan lan kelipatan valuasi:
YCBD - Bathi perusahaan|Bathi sing dikarepake cbdMD, Inc.|YCBD - Koefisien rega marang bathi|Pangali Forward P/E cbdMD, Inc.|YCBD - Rasio P/E diaturake wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan cbdMD Inc.|YCBD - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) cbdMD|YCBD - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan cbdmd.com|YCBD - Wutah bathi saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep cbdMD, Inc.
Pambiji fundamental:cbdMD
Over-the-counter cannabidiol product sales for cbdMD, Inc. (YCBD) depend on consumer demand within the self-care segment and are subject to seasonal fluctuations. By analyzing the company's expected P/E valuation, an investor determines the cost of one dollar of projected earnings, which allows for the distinction between a fundamental discount and a systemic business decline given the brand's sensitivity to macroeconomic shocks and household spending.
Pesaing cbdMD, Inc.
Prakiraan rega marang bathi HLN (Haleon)|KVUE (Kenvue Inc) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Verona Pharma Corp VRNA|Jyong Bio (MENS) - Rasio prakiraan rega marang bathi|LGND: Prakiraan rega marang bathi|amneal.com - Rasio kapitalisasi marang bathi mangsa ngarep|PRGO: Pangali Forward P/E|Alvotech S.A. - Pangali mangsa ngarep rega marang bathi|LQDA (Liquidia Technologies) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Galapagos Corp GLPG|Rega marang bathi mangsa ngarep ANI Pharmaceuticals (ANIP)|MNKD (mannkindcorp.com) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E AMPH (Amphastar Pharmaceuticals, Inc.)|PCRX - Prakiraan rega marang bathi|ARS Pharma - Pangali Forward P/E|TBPH: Rega marang bathi mangsa ngarep|AQST: Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep SCPH|Rega marang bathi mangsa ngarep Tectonic Therapeutic Inc.|Prakiraan rega marang bathi Tonix Pharma (TNXP)|Pangali Forward P/E SXTC|eupraxiapharma.com - Rasio rega marang bathi mangsa ngarep|BioHarvest Sciences - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi EXOZ|Oramed Pharma - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi Entera Bio Ltd. ENTX|MindWalk (HYFT) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep ABVC|CPIX (Cumberland Pharmaceuticals) - Pangali Forward P/E|Prakiraan rega marang bathi quantumbiopharma.com (QNTM)|Prakiraan rega marang bathi FGEN (FibroGen)|Kapitalisasi marang proyeksi bathi Telomir Pharmaceuticals Inc|Rani Therapeutics Holdings, Inc. - Prakiraan rega marang bathi|Synergy CHC Corp. (SNYR) - Rasio prakiraan rega marang bathi|Rallybio Corp. - Pangali Forward P/E|Lexaria Bioscience (LEXX) - Prakiraan rega marang bathi|PULM: Pangali Forward P/E|PTHL (Pheton Holdings) - Rega marang bathi mangsa ngarep|APM (Aptorum Group Ltd) - Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep LYRA (Lyra Therapeutics Inc)|Rega marang bathi mangsa ngarep Impact BioMedical Inc (IBO)|TNFA: Rasio rega marang bathi sing dikarepake|Pangali Forward P/E PRFX (PainReform)|Pangali mangsa ngarep rega marang bathi CYTO|Lipella - Pangali Forward P/E|OPTN - Pangali Forward P/E|Pieris Pharmaceuticals (PIRS) - Rega marang bathi mangsa ngarep|procapsgroup.com - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Petros Pharmaceuticals, Inc.|Prakiraan rega marang bathi Qilian International Holding Group (QLI)|Pangali Forward P/E SLRN|Pangali Forward P/E TFF Pharmaceuticals, Inc (TFFP)
